Skip to content

Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC)

Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02942238
Enrollment
582
Registered
2016-10-24
Start date
2017-01-31
Completion date
2022-12-31
Last updated
2016-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastasis, Overall Survival, Postoperative Complications, Stage, Colon Cancer

Keywords

CME, Right hemi Colon cancer, D3, laparoscopy

Brief summary

To standardize the surgery for advanced right hemi colon cancer with laparoscopy and investigate whether extended lymphadenectomy (CME) could improve disease-free survival in patients with right colon cancer, compared with D3 radical operation in laparoscopic colectomy.

Interventions

PROCEDURECME

the group underwent laparoscopic right hemicolectomy with CME. In CME group, in addition to D2 dissection, the whole mesocolon, from ascending colon to right half transverse colon, as well as the central lymph nodes should be entirely removed. Intervention: Procedure: Complete mesocolic excision (CME)

PROCEDURED3

the group underwent laparoscopic right hemicolectomy with D3 lymph node dissection. In D3 group, the mesocolon should be removed and the dissection involves the paracolon and intermediate lymph nodes,including No.6 lymph node, which along the feeding vessels. Intervention: Procedure: D3 radical operation

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
CollaboratorOTHER
RenJi Hospital
CollaboratorOTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
CollaboratorOTHER
Fudan University
CollaboratorOTHER
Ruijin Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Patients suitable for curative surgery 18-75years old 2. Qualitative diagnosis: a pathological diagnosis of adenocarcinoma; 3. Localization diagnosis: the tumor located between the cecum and the right 1/3 of transverse colon; 4. Enhanced CT scan of chest, abdominal and pelvic cavity: assessment of tumor stage is T stage 1-4 and N stage 0-2; there is no distant metastasis. 5. Informed consent

Exclusion criteria

1. Simultaneous or simultaneous multiple primary colorectal cancer; 2. Preoperative imaging examination results show: (1) Tumor involves the surrounding organs and combined organ resection need to be done; (2)distant metastasis; (3)unable to perform R0 resection; 3. History of any other malignant tumor in recent 5 years; 4. Patients need emergency operation; 5. Not suitable for laparoscopic surgery; 6. Women during Pregnancy or breast feeding period; 7. Informed consent refusal

Design outcomes

Primary

MeasureTime frame
Disease-free survival3 years

Secondary

MeasureTime frame
The rate of postoperative complications and mortality30 days
3 years overall survival3 years
The rate of local and distant recurrence3 years
The accuracy of preoperative staging with CT14 days

Contacts

Primary ContactMinhua Zheng, PhD
zmhtiger@yeah.net+86-13564119545
Backup ContactHiju Hong, PhD Student
jing12722@naver.com+86-13564119545

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026